Investigating genetic factors in a common type of childhood leukemia
Repeat enhancers as drivers of ETV6-RUNX1+ and ETV6-RUNX1-like B-lymphoblastic leukemia
This study is looking at how certain genetic changes in children with B-cell acute lymphoblastic leukemia (B-ALL) can affect their cancer, especially focusing on the ETV6 gene, to help find better treatments for them.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11130145 on NIH RePORTER |
What this research studies
This research focuses on understanding the genetic mechanisms behind B-cell acute lymphoblastic leukemia (B-ALL) in children, particularly those with ETV6 gene alterations. The team will explore how specific genetic changes affect the behavior of leukemia cells, using human cell lines and samples to uncover the role of certain DNA sequences known as GGAA repeats. By studying these mechanisms, the research aims to provide insights that could lead to better treatments for affected children.
Who could benefit from this research
Good fit: Ideal candidates for this research are children under 11 years old who have been diagnosed with B-cell acute lymphoblastic leukemia, particularly those with ETV6 gene alterations.
Not a fit: Patients with other types of leukemia or those over the age of 11 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved therapies and outcomes for children diagnosed with B-ALL.
How similar studies have performed: Previous research has shown promise in understanding genetic factors in leukemia, but this specific approach focusing on GGAA repeat enhancers is relatively novel.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Ryan, Russell James Hubbard — University of Michigan at Ann Arbor
- Study coordinator: Ryan, Russell James Hubbard
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.